يعرض 1 - 10 نتائج من 55 نتيجة بحث عن '"Enfermedad de Hashimoto"', وقت الاستعلام: 1.39s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المساهمون: Rosero Viteri, Iván Andrés, 0107345258

    المصدر: Universidad Católica de Cuenca ; Repositorio Institucional - UCACUE

    الوقت: Cuenca - Ecuador

    وصف الملف: application/pdf; 12 páginas

    العلاقة: Vázquez López AL, Rosero Viteri IA, Tebanta Albán DN, Angamarca Coello MF, León Astudillo EJ. Síndrome Poliglandular Autoinmune Tipo II: Reporte de Caso. Tesla rev. cient. [Internet]. 2 de febrero de 2023 [citado 8 de abril de 2024];3(1):e127. Disponible en: https://tesla.puertomaderoeditorial.com.ar/index.php/tesla/article/view/127Test; https://doi.org/10.55204/trc.v3i1.e127Test; Tesla Revista Científica; 9BT2023-MTI402; https://dspace.ucacue.edu.ec/handle/ucacue/17448Test

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    رسالة جامعية

    المؤلفون: Rivillas Reyes, Juan Felipe

    المساهمون: Zuñiga Pavia, Sergio Fabian, Juan Felipe Rivillas Reyes 0000-0002-2181-7621

    وصف الملف: xiii, 35 páginas; application/pdf

    العلاقة: Kim KW, Park YJ, Kim EH, Park SY, Park DJ, Ahn SH, et al. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto’s thyroiditis. Head Neck. mayo de 2011;33(5):691–5.; Muradas F, Bizarro M, Galleano C. Papillary thyroid carcinoma: Does the association with Hashimoto’s thyroiditis affect the clinicopathological characteristics of the disease? Braz J Otorhinolaryngol. el 1 de mayo de 2015;81(3):283–7.; Hussein O, Abdelwahab K, Hamdy O, Awny S, Megahed NA, Hafez MT, et al. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area. J Egypt Natl Canc Inst. el 1 de diciembre de 2020;32(1).; Jeong JS, Kim HK, Lee CR, Park S, Park JH, Kang SW, et al. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: Clinical manifestation and prognostic outcome. J Korean Med Sci. agosto de 2012;27(8):883–9.; Ehlers M, Schott M. Hashimoto’s thyroiditis and papillary thyroid cancer: Are they immunologically linked? Vol. 25, Trends in Endocrinology and Metabolism. Elsevier Inc.; 2014. p. 656–64.; Jankovic B, Le KT, Hershman JM. Hashimoto’s thyroiditis and papillary thyroid carcinoma: Is there a correlation? Vol. 98, Journal of Clinical Endocrinology and Metabolism. 2013. p. 474–82.; Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H. Is Hashimoto’s Thyroiditis a Risk Factor for Papillary Thyroid Cancer? Journal of Surgical Research. noviembre de 2008;150(1):49–52; de Alcântara-Jones DM, de Alcântara-Nunes TF, de Rocha BO, de Oliveira RD, Santana ACP, de Alcântara FT, et al. Is there any association between Hashimoto’s thyroiditis and thyroid cancer? A retrospective data analysis. Radiol Bras. el 23 de julio de 2015;48(3):148–53.; Lindsay S, Dailey M, Friedlander J, Yee G, Soley M. CHRONIC THYROIDITIS: A CLINICAL AND PATHO-LOGIC STUDY OF 354 PATIENTS*f. 1952.; Dailey M, Lindsay S, Skahen R. RELATION OF THYROID NEOPLASMS TO HASHIMOTO DISEASE OF THE THYROID GLAND. Archives of Surgery. el 1 de febrero de 1955;70(2):291.; Jackson D, Handelsman RS, Farrá JC, Lew JI. Increased Incidental Thyroid Cancer in Patients With Subclinical Chronic Lymphocytic Thyroiditis. Journal of Surgical Research. el 1 de enero de 2020;245:115–8.; Molnár C, Molnár S, Bedekovics J, Mokánszki A, Győry F, Nagy E, et al. Thyroid Carcinoma Coexisting with Hashimoto’s Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis. Pathology and Oncology Research. el 15 de julio de 2019;25(3):1191–7.; Osorio C, Ballestas J, Correa J, Zambrano V, Rosales A, Camargo W, et al. Asociación entre tiroiditis linfocítica crónica y carcinoma papilar de tiroides: Revisión sistemática y metaanálisis de estudios en especímenes quirúrgicos Association between chronic lymphocityc thyroiditis and papillary thyroid carcinoma: Systematic review and meta-analysis of studies on surgical specimens. Revista Colombiana de Cirugia [Internet]. 2023;38:37–49. Disponible en: https://doi.org/10.30944/2011758.2228Test; Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, et al. Hashimoto’s thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngology - Head and Neck Surgery (United States). marzo de 2013;148(3):396–402; Zhang L, Li H, Ji QH, Zhu YX, Wang ZY, Wang Y, et al. The clinical features of papillary thyroid cancer in Hashimoto’s thyroiditis patients from an area with a high prevalence of Hashimoto’s disease [Internet]. 2012. Disponible en: http://www.biomedcentral.com/1471-2407/12/610Test; Ye ZQ, Gu DN, Hu HY, Zhou YL, Hu XQ, Zhang XH. Hashimoto’s Thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer [Internet]. 2013. Disponible en: http://www.wjso.com/content/11/1/56Test; Noureldine S, Tufano RP. Association of Hashimoto’s thyroiditis and thyroid cancer. Vol. 27, Current Opinion in Oncology. Lippincott Williams and Wilkins; 2015. p. 21–5.; Grigerova M, Kasko M, Mojtova E, Takacsova E, Kralik R, Waczulikova I, et al. Infl uence of autoimmune thyroiditis on the prognosis of papillary thyroid carcinoma. Bratislava Medical Journal. 2022;123(12):885–90; Ma B, Chen X, Zhao Z, Yin X, Ji Q, Zhou Y, et al. Coexisting CLT in PTC is an independent predictor of tumor aggressiveness for patients aged under 55: a retrospective analysis of 635 patients. BMC Endocr Disord. el 1 de diciembre de 2022;22(1).; Lee I, Kim HK, Soh EY, Lee J. The Association Between Chronic Lymphocytic Thyroiditis and the Progress of Papillary Thyroid Cancer. World J Surg. el 1 de mayo de 2020;44(5):1506–13; Subhi O, Schulten HJ, Bagatian N, Al-Dayini R, Karim S, Bakhashab S, et al. Genetic relationship between Hashimoto’s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto’s thyroiditis. PLoS One. el 1 de junio de 2020;15(6 June).; de Paiva CR, Grønhøj C, Feldt-Rasmussen U, von Buchwald C. Association between Hashimoto’s thyroiditis and thyroid cancer in 64,628 patients. Front Oncol. el 10 de abril de 2017;7(APR).; Consorti F, Loponte M, Milazzo F, Potasso L, Antonaci A. Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto’s Thyroiditis. European Surgical Research. diciembre de 2010;45(3–4):333–7; Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, et al. Clinical relationship between Hashimoto’s thyroiditis and papillary thyroid cancer. Acta Oncol (Madr). noviembre de 2011;50(8):1228–34; Chen S, Niu C, Peng Q, Tang K. Sonographic Characteristics of Papillary Thyroid Carcinoma With Coexistent Hashimoto’s Thyroiditis in the Preoperative Prediction of Central Lymph Node Metastasis. Front Endocrinol (Lausanne). el 15 de marzo de 2021;12; Cheng V, Brainard J, Nasr C. Co-occurrence of papillary thyroid carcinoma and primary lymphoma of the thyroid in a patient with long-standing Hashimoto’s thyroiditis. Thyroid. el 1 de junio de 2012;22(6):647–50.; Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. el 1 de enero de 2016;26(1):1–133.; Schneider AB, Sarne DH. Long-term risks for thyroid cancer and other neoplasms after exposure to radiation. Vol. 1, Nature clinical practice. Endocrinology & metabolism. 2005. p. 82–91.; Pal T, Vogl FD, Chappuis PO, Tsang R, Brierley J, Renard H, et al. Increased Risk for Nonmedullary Thyroid Cancer in the First Degree Relatives of Prevalent Cases of Nonmedullary Thyroid Cancer: A Hospital-Based Study. 2001.; Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, et al. Identification of Novel Genetic Loci Associated with Thyroid Peroxidase Antibodies and Clinical Thyroid Disease. PLoS Genet. febrero de 2014;10(2).; Mclachlan SM, Feldt-Rasmussen U, Young ET, Middleton SL, Blichert-Toft M, Rees B, et al. IgG SUBCLASS DISTRIBUTION OF THYROID AUTOANTIBODIES: A “FINGERPRINT” OF AN INDIVIDUAL’S RESPONSE TO THYROGLOBULIN AND THYROID MICROSOMAL ANTIGEN. Vol. 26, Clinical Endocrinology. 1987.; Kraiem Z, Lahat N, Glaser B, Baron E, N D M Sheinfeld SA. THYROTROPHIN RECEPTOR BLOCKING ANTIBODIES: INCIDENCE, CHARACTERIZATION AND IN-VITRO SYNTHESIS. Vol. 27, Clinical Endocrinology. 1987.; Tao L, Xi-lin H, Xiang-dong M. Surgical Treatment of Hashimoto’s with Thyroid Microcarcinoma. Cell Biochem Biophys. el 30 de noviembre de 2015;72(1):123–6.; Graceffa G, Patrone R, Vieni S, Campanella S, Calamia S, Laise I, et al. Association between Hashimoto’s thyroiditis and papillary thyroid carcinoma: A retrospective analysis of 305 patients. BMC Endocr Disord. el 29 de mayo de 2019;19; Lee JH, Kim Y, Choi JW, Kim YS. The association between papillary thyroid carcinoma and histologically-2 proven Hashimoto’s thyroiditis: a meta-analysis Corresponding author: Young-Sik. 2012.; Evren B, Yılmaz S, Karadağ N, Sertkaya AÇ, Topaloğlu Ö, Kılınç F. DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter. Sci Rep. el 1 de diciembre de 2021;11(1).; Giagourta I, Evangelopoulou C, Papaioannou G, Kassi G, Zapanti E, Prokopiou M, et al. Autoimmune thyroiditis in benign and malignant thyroid nodules: 16-year results. Head Neck. 2014;36(4):531–5.; Konturek A, Barczyński M, Wierzchowski W, Stopa M, Nowak W. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg. marzo de 2013;398(3):389–94.; Fish SA. Clinical THYROIDOLOGY ® 333 l Hashimoto’s Thyroiditis Is a Risk Factor for Thyroid Cancer [Internet]. Vol. 31. 2019. Disponible en: www.liebertpub.com; Neyd Anil C, Goksel S, Gursoy A. Hashimoto’s Thyroiditis Is Not Associated with Increased Risk of Thyroid Cancer in Patients with Thyroid Nodules: A Single-Center Prospective Study.; Xu J, Ding K, Mu L, Huang J, Ye F, Peng Y, et al. Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid Carcinoma. Front Endocrinol (Lausanne). el 24 de febrero de 2022;13.; Kebebew E, Treseler PA, Ituarte PHG, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg. mayo de 2001;25(5):632–7; Huang BY, Hseuh C, Chao TC, Lin KJ, Lin J Der. Well-differentiated thyroid carcinoma with concomitant Hashimoto’s thyroiditis present with less aggressive clinical stage and low recurrence. Endocr Pathol. septiembre de 2011;22(3):144–9.; Kurukahvecioglu O, Taneri F, Yüksel O, Aydin A, Tezel E, Onuk E. Total Thyroidectomy for the Treatment of Hashimoto’s Thyroiditis Coexisting With Papillary Thyroid Carcinoma; Batool S, Das B, Arif M, Islam N. FREQUENCY OF HASHIMOTO THYROIDITIS IN PAPILLARY THYROID CANCER PATIENTS AND ITS IMPACT ON THEIR OUTCOME [Internet]. Vol. 34, J Ayub Med Coll Abbottabad. 2022. Disponible en: http://www.jamc.ayubmed.edu.pkTest; Tamimi DM. The Association Between Chronic Lymphocytic Thyroiditis and Thyroid Tumors. Vol. 10, International Journal of Surgical Pathology. 2002.; Kim SK, Woo JW, Lee JH, Park I, Choe JH, Kim JH, et al. Chronic lymphocytic thyroiditis and braf v600e in papillary thyroid carcinoma. Endocr Relat Cancer. el 1 de enero de 2016;23(1):27–34.; Kwak HY, Chae BJ, Eom YH, Hong YR, Seo JB, Lee SH, et al. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis? Int J Clin Oncol. el 15 de octubre de 2015;20(3):463–73.; Santoro’ M, Sabino5 N, Ishizaka3 Y, Ushijima3 T, Carlomagnol F, Cerratol A, et al. Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Vol. 68, Br. J. Cancer. 1993.; Lau J, Lee J, Mahipal M, Yang SP, Tan WB, Yuan NK, et al. Hashimoto’s thyroiditis on outcomes in papillary thyroid cancer revisited: experience from South East Asia. Ann R Coll Surg Engl. el 1 de junio de 2022;104(6):465–71.; Konturek A, Barczyński M, Nowak W, Wierzchowski W. Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto’s thyroiditis. Langenbecks Arch Surg. 2014;399(2):229–36.; Asanuma K, Sugenoya A, Kasuga Y, Itoh N, Kobayashi S, Amano J. The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis.; Liang J, Zeng W, Fang F, Yu T, Zhao Y, Fan X, et al. Analisi clinica dell’associazione fra tiroidite di Hashimoto e carcinoma papillare della tiroide in 1392 pazienti. Acta Otorhinolaryngologica Italica. el 1 de octubre de 2017;37(5):393–400.; Campos LAAF, Picado SM, Guimarães AV, Ribeiro DA, Dedivitis RA. Thyroid papillary carcinoma associated to hashimoto’s thyroiditis. Braz J Otorhinolaryngol. 2012;78(6):77–80.; Zhu F, Shen Y Bin, Li FQ, Fang Y, Hu L, Wu YJ. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma. Medicine (United States). el 1 de febrero de 2016;95(6).; Nasiri S, Yazd SMM, Gholami M, Shahriarirad S, Sharghi S, Shahriarirad R. The evaluation of locoregional tumoral involvement in the cooccurrence of hashimoto thyroiditis with papillary thyroid cancer: a case controlled study. BMC Endocr Disord. el 1 de diciembre de 2023;23(1).; Hanege FM, Tuysuz O, Celik S, Sakallıoglu O, Solmaz OA. Hashimoto’s thyroiditis in papillary thyroid carcinoma: A 22-year study. Acta Otorhinolaryngologica Italica. 2021;41(2):142–5.; Tang Q, Pan W, Peng L. Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis. PLoS One. el 1 de junio de 2022;17(6 June).; Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, et al. Increased Incidence of Well-Differentiated Thyroid Cancer Associated with Hashimoto Thyroiditis and the Role of the PI3k/Akt Pathway. J Am Coll Surg. mayo de 2007;204(5):764–73.; Kim SJ, Lee SE, Kim Y Il, Nam-Goong IS, Jung HW, Kim ES. Papillary thyroid cancer with Hashimoto’s thyroiditis attenuates the tumour aggressiveness through the up-regulation of E-cadherin and TGF-β expression. Clin Exp Med. el 1 de julio de 2022; Schäffler A, Palitzsch KD, Seiffarth C, Höhne HM, Riedhammer FJ, Hofstädter F, et al. Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Vol. 28, European Journal of Clinical Investigation. 1998.; Yoon YH, Kim HJ, Lee JW, Kim JM, Koo BS. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. European Archives of Oto-Rhino-Laryngology. marzo de 2012;269(3):1013–7.; Zhang Y, Ma X peng, Deng F sheng, Liu Z rong, Wei H qing, Wang X hong, et al. The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer. World J Surg Oncol. el 1 de septiembre de 2014;12(1).; Selek A, Cetinarslan B, Tarkun I, Canturk Z, Ustuner B, Akyay Z. Thyroid autoimmunity: is really associated with papillary thyroid carcinoma? European Archives of Oto-Rhino-Laryngology. el 1 de marzo de 2017;274(3):1677–81.; Sook Kim E, Jun Lim D, Hyun Baek K, Min Lee J, Kyoung Kim M, Sang Kwon H, et al. Thyroglobulin Antibody Is Associated with Increased Cancer Risk in Thyroid Nodules [Internet]. Disponible en: www.liebertpub.com; Mac Dermott MM, Gauna A, de Yampey JEW. Impacto del compromiso ganglionar en el pronóstico y la evolución del carcinoma papilar de tiroides. Rev Argent Endocrinol Metab. abril de 2017;54(2):51–63.; Donangelo I, Walts AE, Bresee C, Braunstein GD. Lymphocytic thypoiditis is associated with increase number of bening cervical noded and fewer central neck compartment metastatic lymph nodes in patients with differentiated thyroid cancer. Endocrine Practice. 2016;22(10):1192–5.; https://repositorio.unal.edu.co/handle/unal/85276Test; Universidad Nacional de Colombia; Repositorio Institucional Universidad Nacional de Colombia; https://repositorio.unal.edu.coTest/

  8. 8
    تسجيل فيديو
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية